{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:15:10Z","timestamp":1794071710804,"version":"4.8.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00518-z","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:52:37Z","timestamp":1769831557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hearing preservation and restoration surgery in NF2-related schwannomatosis"],"prefix":"10.1007","volume":"25","author":[{"given":"Christopher G.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Huey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred G.","family":"II Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Bradley","family":"Welling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"9","key":"518_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmg-2024-110065","volume":"61","author":"C Forde","year":"2024","unstructured":"Forde C, Smith MJ, Burghel GJ et al (2024) NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study. J Med Genet 61(9):856\u2013860. https:\/\/doi.org\/10.1136\/jmg-2024-110065. (PMID: 38925914)","journal-title":"J Med Genet"},{"issue":"1","key":"518_CR2","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1097\/MAO.0000000000000239","volume":"35","author":"SR Plotkin","year":"2014","unstructured":"Plotkin SR, Merker VL, Muzikansky A, Barker FG 2nd, Slattery W 3rd (2014) Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients. Otol Neurotol 35(1):e50\u2013e56. https:\/\/doi.org\/10.1097\/MAO.0000000000000239","journal-title":"Otol Neurotol"},{"issue":"2","key":"518_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11060-021-03910-8","volume":"156","author":"U Tosi","year":"2022","unstructured":"Tosi U, Maayan O, An A, Lavieri MET, Guadix SW, DeRosa AP, Christos PJ, Pannullo S, Stieg PE, Brandmaier A, Knisely JPS, Ramakrishna R (2022) Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis. J Neurooncol 156(2):431\u2013441. https:\/\/doi.org\/10.1007\/s11060-021-03910-8. (Epub 2022 Jan 18 PMID: 35040021)","journal-title":"J Neurooncol"},{"key":"518_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.wneu.2017.08.159","volume":"109","author":"LK Chung","year":"2018","unstructured":"Chung LK, Nguyen TP, Sheppard JP, Lagman C, Tenn S, Lee P, Kaprealian T, Chin R, Gopen Q, Yang I (2018) A systematic review of radiosurgery versus surgery for neurofibromatosis type 2 vestibular schwannomas. World Neurosurg 109:47\u201358. https:\/\/doi.org\/10.1016\/j.wneu.2017.08.159. (Epub 2017 Sep 4 PMID: 28882713)","journal-title":"World Neurosurg"},{"issue":"6","key":"518_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/MLG.0b013e31804b1ae7","volume":"117","author":"BA Neff","year":"2007","unstructured":"Neff BA, Wiet RM, Lasak JM, Cohen NL, Pillsbury HC, Ramsden RT, Welling DB (2007) Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up. Laryngoscope 117(6):1069\u20131072. https:\/\/doi.org\/10.1097\/MLG.0b013e31804b1ae7","journal-title":"Laryngoscope"},{"issue":"2","key":"518_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3233\/NRE-230198","volume":"54","author":"B Wang","year":"2024","unstructured":"Wang B, Yan M, Liu C, Yang Z, Wang X, Zhao F, Wang Z, Li P, Wang Y, Li S, Liu G, Liu P (2024) Auditory brainstem implants for hearing rehabilitation in NF2-schwannomatosis: a systematic review and single-arm meta-analysis. NeuroRehabilitation 54(2):213\u2013225. https:\/\/doi.org\/10.3233\/NRE-230198. (PMID: 38427506)","journal-title":"NeuroRehabilitation"},{"issue":"4","key":"518_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/MAO.0000000000002994","volume":"42","author":"NL Deep","year":"2021","unstructured":"Deep NL, Patel EJ, Shapiro WH, Waltzman SB, Jethanamest D, McMenomey SO, Roland JT Jr, Friedmann DR (2021) Cochlear implant outcomes in neurofibromatosis type 2: implications for management. Otol Neurotol 42(4):540\u2013548. https:\/\/doi.org\/10.1097\/MAO.0000000000002994","journal-title":"Otol Neurotol"},{"issue":"10","key":"518_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","volume":"54","author":"D Halliday","year":"2017","unstructured":"Halliday D, Emmanouil B, Pretorius P, MacKeith S, Painter S, Tomkins H, Evans DG, Parry A (2017) Genetic severity score predicts clinical phenotype in NF2. J Med Genet 54(10):657\u2013664. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104519. (Epub 2017 Aug 28. PMID: 28848060; PMCID: PMC5740551)","journal-title":"J Med Genet"},{"issue":"3","key":"518_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.otc.2023.02.012","volume":"56","author":"P Jiramongkolchai","year":"2023","unstructured":"Jiramongkolchai P, Schwartz MS, Friedman RA (2023) Management of neurofibromatosis type 2-associated vestibular schwannomas. Otolaryngol Clin North Am 56(3):533\u2013541. https:\/\/doi.org\/10.1016\/j.otc.2023.02.012. (Epub 2023 Mar 22 PMID: 36964092)","journal-title":"Otolaryngol Clin North Am"},{"issue":"5","key":"518_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3171\/2019.6.PEDS1947","volume":"24","author":"I Gugel","year":"2019","unstructured":"Gugel I, Grimm F, Teuber C, Kluwe L, Mautner VF, Tatagiba M, Schuhmann MU (2019) Management of NF2-associated vestibular schwannomas in children and young adults: influence of surgery and clinical factors on tumor volume and growth rate. J Neurosurg Pediatr 24(5):584\u2013592. https:\/\/doi.org\/10.3171\/2019.6.PEDS1947. (PMID: 31443078)","journal-title":"J Neurosurg Pediatr"},{"issue":"6","key":"518_CR11","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/coa.12882","volume":"42","author":"SKW Lloyd","year":"2017","unstructured":"Lloyd SKW, King AT, Rutherford SA, Hammerbeck-Ward CL, Freeman SRM, Mawman DJ, O\u2019Driscoll M, Evans DG (2017) Hearing optimisation in neurofibromatosis type 2: a systematic review. Clin Otolaryngol 42(6):1329\u20131337. https:\/\/doi.org\/10.1111\/coa.12882","journal-title":"Clin Otolaryngol"},{"issue":"4","key":"518_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1056\/NEJMoa0902579","volume":"361","author":"SR Plotkin","year":"2009","unstructured":"Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E (2009) Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 361(4):358\u2013367. https:\/\/doi.org\/10.1056\/NEJMoa0902579. (Epub 2009 Jul 8. PMID: 19587327; PMCID: PMC4816642)","journal-title":"N Engl J Med"},{"issue":"7","key":"518_CR13","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noaa284","volume":"23","author":"C Forde","year":"2021","unstructured":"Forde C, King AT, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SR, Pathmanaban ON, Stapleton E, Thomas OM, Laitt RD, Stivaros S, Kilday JP, Vassallo G, McBain C, Kerrigan S, Smith MJ, McCabe MG, Harkness EF, Evans DG (2021) Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution. Neuro Oncol 23(7):1113\u20131124. https:\/\/doi.org\/10.1093\/neuonc\/noaa284. (PMID: 33336705; PMCID: PMC8248850)","journal-title":"Neuro Oncol"},{"key":"518_CR14","unstructured":"Stec NE, Foureaux-Lee V, Barker FG II, Welling DB, Muzikansky A, Merker V, Orr C. Jordan JT, Plotkin SR (2025) Long-term efficacy and safety of bevacizumab for progressive tumors in patients with NF2-related schwannomatosis. In: Children\u2019s Tumor Foundation Abstracts pg 37, 2025 NF Conference, Washington DC"},{"issue":"4","key":"518_CR15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/lary.27586","volume":"129","author":"B Emmanouil","year":"2019","unstructured":"Emmanouil B, Houston R, May A, Ramsden JD, Hanemann CO, Halliday D, Parry A, Mackeith S (2019) Progression of hearing loss in neurofibromatosis type 2 according to genetic severity. Laryngoscope 129(4):974\u2013980. https:\/\/doi.org\/10.1002\/lary.27586. (Epub 2018 Nov 19 PMID: 30456886)","journal-title":"Laryngoscope"},{"issue":"1","key":"518_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12911-025-02977-x","volume":"25","author":"X Lin","year":"2025","unstructured":"Lin X, Liu C, Wang H, Fan X, Li L, Xu J, Li C, Wang Y, Cai X, Peng X (2025) A SuperLearner approach for predicting diabetic kidney disease upon the initial diagnosis of T2DM in hospital. BMC Med Inform Decis Mak 25(1):148. https:\/\/doi.org\/10.1186\/s12911-025-02977-x. (PMID: 40140809; PMCID: PMC11948915)","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"518_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12911-018-0652-4","volume":"18","author":"Z Chen","year":"2018","unstructured":"Chen Z, Bird VY, Ruchi R, Segal MS, Bian J, Khan SR, Elie MC, Prosperi M (2018) Development of a personalized diagnostic model for kidney stone disease tailored to acute care by integrating large clinical, demographics and laboratory data: the diagnostic acute care algorithm - kidney stones (DACA-KS). BMC Med Inform Decis Mak 18(1):72. https:\/\/doi.org\/10.1186\/s12911-018-0652-4. (PMID: 30119627; PMCID: PMC6098647)","journal-title":"BMC Med Inform Decis Mak"},{"issue":"5","key":"518_CR18","first-page":"644","volume":"20","author":"DB Welling","year":"1999","unstructured":"Welling DB, Slater PW, Thomas RD, McGregor JM, Goodman JE (1999) The learning curve in vestibular schwannoma surgery. Am J Otol 20(5):644\u2013648 (PMID: 10503588)","journal-title":"Am J Otol"},{"issue":"3","key":"518_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s0385-8146(01)00086-4","volume":"28","author":"J Kanzaki","year":"2001","unstructured":"Kanzaki J, Inoue Y, Ogawa K (2001) The learning curve in post-operative hearing results in vestibular schwannoma surgery. Auris Nasus Larynx 28(3):209\u2013213. https:\/\/doi.org\/10.1016\/s0385-8146(01)00086-4. (PMID: 11489362)","journal-title":"Auris Nasus Larynx"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00518-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00518-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00518-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:52:38Z","timestamp":1769831558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00518-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00518-z","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors disclosure no conflicts of interest. DBW is a consultant for Salubritas, Inc. SRP is co-founder of NFlection Therapeutics and NF2 Therapeutics; consults for Akouos; and is on the scientific advisory board of SonALAsense.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"14"}}